Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Stem Cell Research & Therapy|December 5, 2021
Cytokine-induced memory-like natural killer cells for cancer immunotherapyMubin Tarannum, Rizwan RomeeStem Cells Translational Medicine|December 24, 2023
Genetic Manipulation Approaches to Enhance the Clinical Application of NK Cell-Based ImmunotherapyAndreia Maia, Mubin Tarannum, Rizwan RomeeAdvanced Drug Delivery Reviews|May 23, 2022
Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatmentMubin Tarannum, Juan L Vivero-EscotoCancer Journal (Sudbury, Mass.)|March 22, 2021
Is Adoptive Cellular Therapy With Non-T-Cell Immune Effectors the Future?Alaa Kassim Ali, Mubin Tarannum, Rizwan RomeeFrontiers in Immunology|April 11, 2022
Innovative Strategies to Improve the Clinical Application of NK Cell-Based ImmunotherapyMubin Tarannum, Rizwan Romee, Roman M ShapiroJournal of Materials Chemistry. B|May 3, 2016
Cellular Endocytosis and Trafficking of Cholera Toxin B-Modified Mesoporous Silica NanoparticlesWilliam A Walker, Mubin Tarannum, Juan L Vivero-EscotoAdvanced Healthcare Materials|April 23, 2024
Mesoporous Silica Nanoparticles as an Ideal Platform for Cancer Immunotherapy: Recent Advances and Future DirectionsVarsha Godakhindi, Mubin Tarannum, Sudip Kumar Dam, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 15, 2022
Nanoparticle combination for precise stroma modulation and improved delivery for pancreatic cancerMubin Tarannum, Katherine Holtzman, Didier Dréau, et al.Molecular Therapy. Oncology|March 5, 2026
Beyond autologous ex vivo CAR-expressing cell therapies: Toward allogeneic and nucleated cell-free delivery systems of CARKathrine S Rallis, Laura M Dionisio, Mubin Tarannum, et al.Nature Biotechnology|April 14, 2025
Engineering innate immune cells for cancer immunotherapyMubin Tarannum, Xizhong Ding, Marta Barisa, et al.Pageof 3